660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update

Autor:	Tomas Buchler, Pablo Maroto, Sun Young Rha, Thomas Powles, Toni K. Choueiri, Viktor Grünwald, M.J. Méndez-Vidal, Karla Rodriguez-Lopez, S-H. Hong, Camillo Porta, Eric Winquist, Thomas E. Hutson, Masatoshi Eto, Robert J. Motzer, Evgeny Kopyltsov, Jeffrey C. Goh, Alan D. Smith, T. Takagi, Dongyuan Xing
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Renal cell carcinoma business.industry Internal medicine Toxicity medicine Hematology medicine.disease business
Zdroj:	Annals of Oncology. 32:S683-S685
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.056
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f88be990ae1ccafedc9a09544eb8e81c https://doi.org/10.1016/j.annonc.2021.08.056 Zobrazit plný text záznamu